Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-22

FDA Approved: PHENYTOIN INFATABS — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for Phenytoin Infatabs (phenytoin) submitted by Prasco Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PHENYTOIN INFATABS (Phenytoin)

Snippet

SUPPL AP for PHENYTOIN INFATABS (PHENYTOIN)